Niche market fit Small biotechnology research firm with a long-standing LIMS and LTM automation product (LABCAT) serving pharmacology, toxicology, pathology, and oncology. Potential upsell opportunities in expanding modules for GLP-compliant workflows and additional animal study automation features.

SMB sales potential Headcount 2-10 indicates a small business with growing needs. Focus on scalable licensing, flexible deployment options, and quick ROI demonstrations to win expansion licenses or add-on modules as they scale.

Stable revenue range Revenue estimated between $1M and $10M suggests a solid footprint but opportunity to target governance, compliance, and cost-efficiency requests. Propose value-based pricing, renewals, and tiered support that aligns with their GLP-focused requirements.

Tech stack alignment Current tech stack includes MySQL, jQuery, SEO tools, and hosting services. Leverage integration capabilities with existing data ecosystems, offer modernization options, and emphasize security and compliance features relevant to regulated labs.

Global classroom of users LABCAT serves pharma, government, academia, CROs and biotech. This breadth opens cross-selling in adjacent sectors, partner channels, and ROI case studies to accelerate credibility when approaching similar mid-market prospects in these segments.